Presenter: Christy Carter, Assistant Professor, Department of Aging and Geriatric Research, Institute on Aging, University of Florida. Dr. Carter received her PhD in Experimental and Biological Psychology from the University of North Carolina at Chapel Hill and her post-doctoral training at The Wake Forest University School of Medicine in Winston-Salem, North Carolina.
Globally , Dr. Carter’s current research interests lie in preserving physical function and healthspan during aging; and in particular focuses on the use of a preclinical rodent model of aging to test a variety of late-life interventions designed to mitigate sarcopenia. Furthermore, she has demonstrated that the application of standardized physical performance measures to a variety of animal models of aging may help to define similarities between species in the underlying mechanisms of sarcopenia, the age-related decline in performance, disability, and longevity. Indeed the assessment of behavioral outcomes is essential for measuring the efficacy of any late-life intervention in the context of mitigating declining performance and improving healthspan. She has extended this area of research to other special aging populations such as the frail and obese, and has developed combinatorial therapies, using these compounds in conjunction with behavioral modification such as exercise.
Rejuvenation Biotechnology 2014 Musculoskeletal Disease Session (August 23, 2014, 12:30pm) "What is Sarcopenia? Definitions, Diagnosis and Developing Interventions"
Presenter: Christy Carter, Assistant Professor, Department of Aging and Geriatric Research, Institute on Aging, University of Florida. Dr. Carter received her PhD in Experimental and Biological Psychology from the University of North Carolina at Chapel Hill and her post-doctoral training at The Wake Forest University School of Medicine in Winston-Salem, North Carolina.
Globally , Dr. Carter’s current research interests lie in preserving physical function and healthspan during aging; and in particular focuses on the use of a preclinical rodent model of aging to test a variety of late-life interventions designed to mitigate sarcopenia. Furthermore, she has demonstrated that the application of standardized physical performance measures to a variety of animal models of aging may help to define similarities between species in the underlying mechanisms of sarcopenia, the age-related decline in performance, disability, and longevity. Indeed the assessment of behavioral outcomes is essential for measuring the efficacy of any late-life intervention in the context of mitigating declining performance and improving healthspan. She has extended this area of research to other special aging populations such as the frail and obese, and has developed combinatorial therapies, using these compounds in conjunction with behavioral modification such as exercise.
https://www.youtube.com/watch?v=s1TuuFAcLVM